Rare Genomics Institute announces new director and CEO

The Rare Genomics Institute — a nonprofit in Hanover, Md., that connects rare disease patients with research technology and experts — has announced Paul Schindler as its new executive director and CEO.

Advertisement

Mr. Schindler has more than 10 years of experience in community development and nearly 20 years in entrepreneurship.

Prior to joining the Rare Genomics Institute, Mr. Schindler served as vice president of operations for Kreiger Consulting. He was also the founder, president and CEO of Living Hope Community Partnership, a community organization that helped families dealing with human trafficking, child hunger and other issues.

 

More articles on genomics:
Increased genomic testing drives need for more efficient data storage
NorthShore University HealthSystem launches Pharmacogenomics Clinic
Researchers to use ‘Internet of genomics’ to treat orphan diseases

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Executive Moves

  • Cookeville (Tenn.) Regional Medical Center has named Greg Anderson its new CFO, The UC Now reported July 21.  Mr. Anderson…

  • Hospital and health system CEOs across the U.S. have made several moves recently, including appointments at new organizations and departures.…

  • Renton, Wash.-based Providence has named Brad Myers, PharmD, as chief pharmacy officer, effective Aug. 24. Dr. Myers currently serves as…

Advertisement

Comments are closed.